View source for PARKINSONS (MILD TO MODERATE) Tx-DOPAMINE AGONISTS

===== [[Summary Article|'''SUMMARY''']] =====
1. Non-ergot derived dopamine agonists <b>(ropinirole and pramipexole)</b> can be useful as mono-therapy, but 60% of patients will require adjunctive L-dopa after 4 years.
<br/>
<br/>2. Know that these dopa agonists, ropinirole and pramipexole, are associated with impulse control disorders, such as hypersexuality, compulsive shopping, and pathological gambling.


==Reference(s)==
Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. [https://amzn.to/3YHrI6K Get it on Amazon.]
<br/>Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. [https://amzn.to/3k7WSW0 Get it on Amazon.]
<br/>Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
<br/>Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].

[[Category:Parkinsons (Mild To Moderate) Tx]]
[[Category:Neurology]]
[[Category:Medicine]]